Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,625 | -3,493 | -1,309 | -3,933 | -2,818 |
| Depreciation Amortization | 30 | 22 | 11 | 55 | 44 |
| Income taxes - deferred | -137 | -92 | -41 | -81 | -53 |
| Accounts receivable | 14 | -40 | 53 | -121 | -103 |
| Accounts payable and accrued liabilities | -1 | -16 | -4 | 50 | 3 |
| Other Working Capital | 312 | 359 | 639 | 598 | 653 |
| Other Operating Activity | 3,030 | 1,214 | 19 | 297 | 635 |
| Operating Cash Flow | $-2,376 | $-2,047 | $-631 | $-3,135 | $-1,639 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | N/A | -18 | -18 |
| Sale Of Investment | 137 | 33 | N/A | N/A | N/A |
| Other Investing Activity | -470 | 0 | 0 | -18 | -17 |
| Investing Cash Flow | $-333 | $33 | $N/A | $-35 | $-35 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 685 | 204 | 281 | 658 | 1,846 |
| Debt Issued | 124 | 124 | 72 | 388 | 958 |
| Debt Repayment | -264 | -263 | -10 | 958 | -852 |
| Common Stock Issued | 2,153 | 2,191 | 268 | 1,084 | 531 |
| Financing Cash Flow | $2,699 | $2,255 | $610 | $3,088 | $2,483 |
| Exchange Rate Effect | 1 | 5 | 0 | 0 | 0 |
| Beginning Cash Position | 160 | 160 | 160 | 243 | 243 |
| End Cash Position | 152 | 406 | 140 | 160 | 1,052 |
| Net Cash Flow | $-9 | $246 | $-21 | $-82 | $809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,376 | -2,047 | -631 | -3,135 | -1,639 |
| Free Cash Flow | -2,376 | -2,047 | -631 | -3,135 | -1,639 |